C-reactive protein is a prognostic parameter in patients with cervical cancer.
OBJECTIVE
To evaluate whether C-reactive protein (CRP) serum levels can be used as a prognostic parameter in patients with cervical cancer.


METHODS
In the present study, CRP serum levels were measured in 215 patients with cervical cancer. CRP serum levels were measured prior to therapy for cervical cancer and were correlated to clinical data.


RESULTS
The median CRP serum level in patients with cervical cancer was 0.5 mg/dl (interquartile range 0.5-0.9 mg/dl). CRP serum levels were significantly associated with advanced tumor stage (p<0.001), lymph node involvement (p=0.01) and patients' age (p=0.01), but not with histological grade (p=0.1) and histological type (p=0.9). In a univariate and multivariate analysis CRP serum levels, tumor stage, and lymph node involvement, but not histological grade, histological type and patients' age were associated with overall and disease-free survival.


CONCLUSIONS
CRP serum levels can be used as additional prognostic parameter in patients with cervical cancer.
Polterauer
Stephan
S
Department of Obstetrics and Gynecology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Grimm
Christoph
C
Tempfer
Clemens
C
Sliutz
Gerhard
G
Speiser
Paul
P
Reinthaller
Alexander
A
Hefler
Lukas A
LA
D014408:Biomarkers, Tumor / Q000032:analysis; D002097:C-Reactive Protein / Q000378:metabolism*; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D011379:Prognosis; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000097:blood* / Q000401:mortality / Q000473:pathology
D014408:Biomarkers, Tumor; D002097:C-Reactive Protein